Synopsis
0
KDMF
0
VMF
0
FDF
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
DOSAGE - TABLET;ORAL-28 - 0.02MG;1MG
USFDA APPLICATION NUMBER - 17354
DOSAGE - TABLET;ORAL-21 - 0.03MG;1.5MG
USFDA APPLICATION NUMBER - 17355
DOSAGE - TABLET;ORAL-21 - 0.03MG;1.5MG
USFDA APPLICATION NUMBER - 17875
DOSAGE - TABLET;ORAL-21 - 0.02MG;1MG **Federa...DOSAGE - TABLET;ORAL-21 - 0.02MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
USFDA APPLICATION NUMBER - 17876
DOSAGE - TABLET;ORAL-21 - 0.02MG,0.03MG,0.035...DOSAGE - TABLET;ORAL-21 - 0.02MG,0.03MG,0.035MG;1MG,1MG,1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
USFDA APPLICATION NUMBER - 20130
DOSAGE - TABLET;ORAL - 0.02MG;1MG **Federal R...DOSAGE - TABLET;ORAL - 0.02MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
USFDA APPLICATION NUMBER - 203667
DOSAGE - INJECTABLE, TABLET;INTRAMUSCULAR, OR...DOSAGE - INJECTABLE, TABLET;INTRAMUSCULAR, ORAL - 11.25MG/VIAL,N/A;N/A,5MG
USFDA APPLICATION NUMBER - 203696
DOSAGE - INJECTABLE, TABLET;INTRAMUSCULAR, OR...DOSAGE - INJECTABLE, TABLET;INTRAMUSCULAR, ORAL - 3.75MG/VIAL,N/A;N/A,5MG
USFDA APPLICATION NUMBER - 203696
DOSAGE - CAPSULE;ORAL - 0.02MG;1MG
USFDA APPLICATION NUMBER - 204426
DOSAGE - TABLET, CHEWABLE, TABLET;ORAL - 0.01...DOSAGE - TABLET, CHEWABLE, TABLET;ORAL - 0.01MG,0.01MG,N/A;1MG,N/A,N/A
USFDA APPLICATION NUMBER - 204654
DOSAGE - FILM, EXTENDED RELEASE;TRANSDERMAL -...DOSAGE - FILM, EXTENDED RELEASE;TRANSDERMAL - 0.05MG/24HR;0.14MG/24HR
USFDA APPLICATION NUMBER - 20870
DOSAGE - FILM, EXTENDED RELEASE;TRANSDERMAL -...DOSAGE - FILM, EXTENDED RELEASE;TRANSDERMAL - 0.05MG/24HR;0.25MG/24HR
USFDA APPLICATION NUMBER - 20870
DOSAGE - TABLET;ORAL - 0.5MG;0.1MG **Federal ...DOSAGE - TABLET;ORAL - 0.5MG;0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
USFDA APPLICATION NUMBER - 20907
DOSAGE - TABLET;ORAL - 1MG;0.5MG
USFDA APPLICATION NUMBER - 20907
DOSAGE - TABLET;ORAL - 0.0025MG;0.5MG
USFDA APPLICATION NUMBER - 21065
DOSAGE - TABLET;ORAL - 0.005MG;1MG **Federal ...DOSAGE - TABLET;ORAL - 0.005MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
USFDA APPLICATION NUMBER - 21065
DOSAGE - TABLET;ORAL - 0.02MG;1MG **Federal R...DOSAGE - TABLET;ORAL - 0.02MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
USFDA APPLICATION NUMBER - 21871
DOSAGE - TABLET;ORAL - 0.01MG,0.01MG;1MG,N/A
USFDA APPLICATION NUMBER - 22501
Related Excipient Companies
Rochem International Inc
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Faran Shimi Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Boai NKY Pharmaceuticals Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pfanstiehl
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ACG Worldwide
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Aeon Procare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Alcedo Pharmachem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Clariant
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Corel Pharma Chem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DFE Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Doshion Polyscience
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Huzhou Sunflower Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ideal Cures Pvt Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ingredion Pharma Solutions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kima Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Lonza Capsugel
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Microlex e.U
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Bold Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Novo Excipients
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pharmatrans-Sanaq
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Prachin Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Qianhao Chemical (Hebei) Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Qualicaps
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Roquette
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Seppic
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Shenmei Pharmaceutical Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Welltone Material Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Sigachi Industries
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]The Dow Chemical Company
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ulanqab Kema New Material
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Fillers, Diluents & Binders
Coating Systems & Additives
Disintegrants & Superdisintegrants
Direct Compression
Controlled & Modified Release
Granulation
Solubilizers
Thickeners and Stabilizers
Lubricants & Glidants
Taste Masking
Film Formers & Plasticizers
Parenteral
Co-Processed Excipients
Emulsifying Agents
Topical
API Stability Enhancers
Chewable & Orodispersible Aids
Rheology Modifiers
Coloring Agents
Empty Capsules
Surfactant & Foaming Agents
Vegetarian Capsules
Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
89
PharmaCompass offers a list of Norethisterone Acetate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Norethisterone Acetate manufacturer or Norethisterone Acetate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Norethisterone Acetate manufacturer or Norethisterone Acetate supplier.
PharmaCompass also assists you with knowing the Norethisterone Acetate API Price utilized in the formulation of products. Norethisterone Acetate API Price is not always fixed or binding as the Norethisterone Acetate Price is obtained through a variety of data sources. The Norethisterone Acetate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A 19-Norpregn-4-en-20-yn-3-one, 17-(acetyloxy)-, (17alpha) manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 19-Norpregn-4-en-20-yn-3-one, 17-(acetyloxy)-, (17alpha), including repackagers and relabelers. The FDA regulates 19-Norpregn-4-en-20-yn-3-one, 17-(acetyloxy)-, (17alpha) manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 19-Norpregn-4-en-20-yn-3-one, 17-(acetyloxy)-, (17alpha) API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of 19-Norpregn-4-en-20-yn-3-one, 17-(acetyloxy)-, (17alpha) manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A 19-Norpregn-4-en-20-yn-3-one, 17-(acetyloxy)-, (17alpha) supplier is an individual or a company that provides 19-Norpregn-4-en-20-yn-3-one, 17-(acetyloxy)-, (17alpha) active pharmaceutical ingredient (API) or 19-Norpregn-4-en-20-yn-3-one, 17-(acetyloxy)-, (17alpha) finished formulations upon request. The 19-Norpregn-4-en-20-yn-3-one, 17-(acetyloxy)-, (17alpha) suppliers may include 19-Norpregn-4-en-20-yn-3-one, 17-(acetyloxy)-, (17alpha) API manufacturers, exporters, distributors and traders.
click here to find a list of 19-Norpregn-4-en-20-yn-3-one, 17-(acetyloxy)-, (17alpha) suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A 19-Norpregn-4-en-20-yn-3-one, 17-(acetyloxy)-, (17alpha) DMF (Drug Master File) is a document detailing the whole manufacturing process of 19-Norpregn-4-en-20-yn-3-one, 17-(acetyloxy)-, (17alpha) active pharmaceutical ingredient (API) in detail. Different forms of 19-Norpregn-4-en-20-yn-3-one, 17-(acetyloxy)-, (17alpha) DMFs exist exist since differing nations have different regulations, such as 19-Norpregn-4-en-20-yn-3-one, 17-(acetyloxy)-, (17alpha) USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A 19-Norpregn-4-en-20-yn-3-one, 17-(acetyloxy)-, (17alpha) DMF submitted to regulatory agencies in the US is known as a USDMF. 19-Norpregn-4-en-20-yn-3-one, 17-(acetyloxy)-, (17alpha) USDMF includes data on 19-Norpregn-4-en-20-yn-3-one, 17-(acetyloxy)-, (17alpha)'s chemical properties, information on the facilities and procedures used, and details about packaging and storage. The 19-Norpregn-4-en-20-yn-3-one, 17-(acetyloxy)-, (17alpha) USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of 19-Norpregn-4-en-20-yn-3-one, 17-(acetyloxy)-, (17alpha) suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The 19-Norpregn-4-en-20-yn-3-one, 17-(acetyloxy)-, (17alpha) Drug Master File in Japan (19-Norpregn-4-en-20-yn-3-one, 17-(acetyloxy)-, (17alpha) JDMF) empowers 19-Norpregn-4-en-20-yn-3-one, 17-(acetyloxy)-, (17alpha) API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the 19-Norpregn-4-en-20-yn-3-one, 17-(acetyloxy)-, (17alpha) JDMF during the approval evaluation for pharmaceutical products. At the time of 19-Norpregn-4-en-20-yn-3-one, 17-(acetyloxy)-, (17alpha) JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of 19-Norpregn-4-en-20-yn-3-one, 17-(acetyloxy)-, (17alpha) suppliers with JDMF on PharmaCompass.
A 19-Norpregn-4-en-20-yn-3-one, 17-(acetyloxy)-, (17alpha) CEP of the European Pharmacopoeia monograph is often referred to as a 19-Norpregn-4-en-20-yn-3-one, 17-(acetyloxy)-, (17alpha) Certificate of Suitability (COS). The purpose of a 19-Norpregn-4-en-20-yn-3-one, 17-(acetyloxy)-, (17alpha) CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of 19-Norpregn-4-en-20-yn-3-one, 17-(acetyloxy)-, (17alpha) EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of 19-Norpregn-4-en-20-yn-3-one, 17-(acetyloxy)-, (17alpha) to their clients by showing that a 19-Norpregn-4-en-20-yn-3-one, 17-(acetyloxy)-, (17alpha) CEP has been issued for it. The manufacturer submits a 19-Norpregn-4-en-20-yn-3-one, 17-(acetyloxy)-, (17alpha) CEP (COS) as part of the market authorization procedure, and it takes on the role of a 19-Norpregn-4-en-20-yn-3-one, 17-(acetyloxy)-, (17alpha) CEP holder for the record. Additionally, the data presented in the 19-Norpregn-4-en-20-yn-3-one, 17-(acetyloxy)-, (17alpha) CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the 19-Norpregn-4-en-20-yn-3-one, 17-(acetyloxy)-, (17alpha) DMF.
A 19-Norpregn-4-en-20-yn-3-one, 17-(acetyloxy)-, (17alpha) CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. 19-Norpregn-4-en-20-yn-3-one, 17-(acetyloxy)-, (17alpha) CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of 19-Norpregn-4-en-20-yn-3-one, 17-(acetyloxy)-, (17alpha) suppliers with CEP (COS) on PharmaCompass.
A 19-Norpregn-4-en-20-yn-3-one, 17-(acetyloxy)-, (17alpha) written confirmation (19-Norpregn-4-en-20-yn-3-one, 17-(acetyloxy)-, (17alpha) WC) is an official document issued by a regulatory agency to a 19-Norpregn-4-en-20-yn-3-one, 17-(acetyloxy)-, (17alpha) manufacturer, verifying that the manufacturing facility of a 19-Norpregn-4-en-20-yn-3-one, 17-(acetyloxy)-, (17alpha) active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting 19-Norpregn-4-en-20-yn-3-one, 17-(acetyloxy)-, (17alpha) APIs or 19-Norpregn-4-en-20-yn-3-one, 17-(acetyloxy)-, (17alpha) finished pharmaceutical products to another nation, regulatory agencies frequently require a 19-Norpregn-4-en-20-yn-3-one, 17-(acetyloxy)-, (17alpha) WC (written confirmation) as part of the regulatory process.
click here to find a list of 19-Norpregn-4-en-20-yn-3-one, 17-(acetyloxy)-, (17alpha) suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing 19-Norpregn-4-en-20-yn-3-one, 17-(acetyloxy)-, (17alpha) as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for 19-Norpregn-4-en-20-yn-3-one, 17-(acetyloxy)-, (17alpha) API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture 19-Norpregn-4-en-20-yn-3-one, 17-(acetyloxy)-, (17alpha) as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain 19-Norpregn-4-en-20-yn-3-one, 17-(acetyloxy)-, (17alpha) and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a 19-Norpregn-4-en-20-yn-3-one, 17-(acetyloxy)-, (17alpha) NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of 19-Norpregn-4-en-20-yn-3-one, 17-(acetyloxy)-, (17alpha) suppliers with NDC on PharmaCompass.
19-Norpregn-4-en-20-yn-3-one, 17-(acetyloxy)-, (17alpha) Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 19-Norpregn-4-en-20-yn-3-one, 17-(acetyloxy)-, (17alpha) GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 19-Norpregn-4-en-20-yn-3-one, 17-(acetyloxy)-, (17alpha) GMP manufacturer or 19-Norpregn-4-en-20-yn-3-one, 17-(acetyloxy)-, (17alpha) GMP API supplier for your needs.
A 19-Norpregn-4-en-20-yn-3-one, 17-(acetyloxy)-, (17alpha) CoA (Certificate of Analysis) is a formal document that attests to 19-Norpregn-4-en-20-yn-3-one, 17-(acetyloxy)-, (17alpha)'s compliance with 19-Norpregn-4-en-20-yn-3-one, 17-(acetyloxy)-, (17alpha) specifications and serves as a tool for batch-level quality control.
19-Norpregn-4-en-20-yn-3-one, 17-(acetyloxy)-, (17alpha) CoA mostly includes findings from lab analyses of a specific batch. For each 19-Norpregn-4-en-20-yn-3-one, 17-(acetyloxy)-, (17alpha) CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
19-Norpregn-4-en-20-yn-3-one, 17-(acetyloxy)-, (17alpha) may be tested according to a variety of international standards, such as European Pharmacopoeia (19-Norpregn-4-en-20-yn-3-one, 17-(acetyloxy)-, (17alpha) EP), 19-Norpregn-4-en-20-yn-3-one, 17-(acetyloxy)-, (17alpha) JP (Japanese Pharmacopeia) and the US Pharmacopoeia (19-Norpregn-4-en-20-yn-3-one, 17-(acetyloxy)-, (17alpha) USP).
